Everything below concerns HPLC-UV. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-01. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical laboratories commonly use high-performance liquid chromatography to separate creatine from creatinine and related impurities. Ion chromatography, nuclear magnetic resonance, and titration assays can also quantify the compound. Water content is measured by Karl Fischer titration or loss on drying, because the monohydrate has a defined theoretical water fraction. Particle size, bulk density, and flowability are physical properties that affect blending and capsule filling. These measurements support quality control and help verify that a lot matches its specification.
Regulatory status varies by country. In the United States, creatine monohydrate is sold as a dietary supplement ingredient, while in the European Union it is placed on the market as a food supplement component. Some jurisdictions have established purity monographs or permitted health claims, while others treat it as a novel food or require notification. Product labels may state the amount of creatine monohydrate or the equivalent creatine content, and the two figures can differ. Independent testing programs sometimes check identity, potency, and contaminant limits.
Commercial creatine products appear in several forms, including monohydrate, hydrochloride, citrate, nitrate, and ethyl ester. Creatine monohydrate is the most studied form and serves as a reference material in comparative research. Different forms vary in solubility, pH, and water content, but they share creatine as the active moiety after dissolution. Claims that one form is uniformly superior remain debated, and study designs often differ in population, exercise protocol, and outcome measures. Purity and hydration state are central to interpreting product labels.
Creatine monohydrate is the hydrated form of creatine, a nitrogen-containing organic acid involved in cellular energy transfer. Its molecular formula is C4H11N3O3, and it consists of creatine plus one water molecule in the crystal lattice. The anhydrous base, creatine, has the formula C4H9N3O2. The compound appears as a white, odorless, crystalline powder and is classified as a guanidine derivative. It is distinct from creatinine, a breakdown product measured in clinical chemistry.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 15-25 °C | Sealed container; protect from moisture and direct heat. |
| Theoretical water content | About 12.1% | One water molecule per creatine molecule. |
| Primary degradation product | Creatinine | Formed by cyclization, especially in aqueous solution. |
| Common analytical method | HPLC-UV | Used to separate creatine from creatinine and related impurities. |
| Regulatory classification (U.S.) | Dietary supplement ingredient | Other jurisdictions may classify it as a food supplement or novel food depending on rules. |
Creatine is synthesized endogenously in humans, mainly in the liver, kidney, and pancreas, from the amino acids arginine, glycine, and methionine. Skeletal muscle stores much of the body's creatine, where it participates in the phosphocreatine system that buffers adenosine triphosphate during short, intense contractions. Dietary sources include meat and fish, so omnivorous diets provide additional creatine beyond endogenous production. Supplemental creatine monohydrate supplies the same molecule found in food and tissues, not a distinct drug or hormone. Research interest centers on its role in cellular energy transfer and its effects on muscle and other tissues.
Several creatine forms are sold, including monohydrate, anhydrous, hydrochloride, nitrate, citrate, and blends. Once dissolved, these forms deliver creatine, but they differ in molar mass, solubility, counterions, and water content. Creatine monohydrate has the largest body of published human data among these forms. Questions remain about whether any alternative form offers meaningful advantages in absorption, tolerability, or tissue uptake under practical conditions. The hydrate form's lower creatine content by mass is a compositional fact, not a statement about effectiveness.
== Awards and honours == 2011 Royal Society of Edinburgh Young Academy of Scotland 2018 Wellcome Trust Prize for Outstanding Achievement in Public Engagement in the Biomedical Sciences 2018 "Super Zena" Award 2022 Royal Society of Edinburgh elected Fellow of the Royal Society of Edinburgh (FRSE)
The rate of proteolysis may also depend on the physiological state of the organism, such as its hormonal state as well as nutritional status. In time of starvation, the rate of protein degradation increases.
Eugenol is an allyl chain-substituted guaiacol, a member of the allylbenzene class of chemical compounds. It is a colorless to pale yellow, aromatic oily liquid extracted from certain essential oils especially from clove, nutmeg, cinnamon, basil and bay leaf. It is present in concentrations of 80–90% in clove bud oil and at 82–88% in clove leaf oil. Containing eugenol, clove essential oil is obtained from unopened clove buds. Eugenol has a pleasant, spicy, clove-like scent. The name is derived from Eugenia caryophyllata, the former Linnaean nomenclature term for cloves. The currently accepted name is Syzygium aromaticum.
For services to the Arts and to the community in Southend-on-Sea, Essex. Dr. Alasdair Cunningham Bruce. Boston Spa Renewed Programme Manager. For services to Libraries. Christopher John Paul Bryant. Director of Tournaments and Events, Football Association. For services to Sport. Jennifer Sheridan Bryer. Teacher, Pony Club. For services to Horse Riding. Peter George Buchan. Managing Director, Shipping, Nuclear Transport Solutions. For services to the Nuclear Industry and to Young People. Khumi Tonsing Burton, JP, DL. For services to the community in Manchester and Cheshire. Ronald Butler. Policy Adviser, Department for Work and Pensions. For services to Disadvantaged People. Carrie Byrom. Director, Stable Lives. For services to Mental Health and the community in North West England. David Corrie Calvert. President, Langholm Town Band. For services to the community in Langholm, Dumfries. Carl Campbell. Founder and Artistic Director, CCDC7. For services to African Caribbean Dance Education and Culture. Catriona Yvonne Fiona Campbell. UK&I Chief Technology and Innovation Officer, EY. For services to Technology and Innovation. George Alan Carney. Executive Officer, Department for Education. For Public Service. Professor Kathryn Janice Carruthers. Professor of French Linguistics, Queen's University Belfast. For services to Modern Languages. Kathryn Melanie Keele Caton. Founder and Managing Director, Brighton Gin. For services to Trade and to the community in Brighton. Amanda Chadwick. Founder and Trustee, Pyjama Fairies. For services to Children in Hospital. Edward Kay Kiu Chan.
Petersburg, Florida, was subject to an FCA claim that resulted in a total judgment of US$1.179 million on 214 fraudulent claims to Medicare that totaled US$755.54 stemming from the lack of a CLIA certificate. The oncology practice had its own CLIA certificate and acquired another oncology clinic with an in-house lab, but did not obtain the clinic's CLIA license, so the existing CLIA certificate did not cover the new practice. Because the lab at the newly acquired oncology practice lacked a proper CLIA certificate, reimbursement was denied. The practice opted to resubmit the bills to fraudulently claim the tests were performed at an office with a valid CLIA certificate. In doing so 214 times, the federal government suffered $755.54 in damages. The court trebled the damages to $2,266.62 and imposed the minimum statutory penalty of $5,500 per violation for each of the 214 violations. The Eleventh circuit noted that "[s]eeing a judgment of $1.179 million based on $755.54 in actual damages may raise an eyebrow," noting that "[f]raud harms the United States in ways untethered to the value of any ultimate payment" and that "[i]n the context of the FCA, we also consider the deterrent effect of a monetary award."
Sources: en.wikipedia.org
[1] [2] Buprenorphine versus naltrexone Naltrexone is a full antagonist to the mu-opioid receptor, while buprenorphine is a partial-agonist, this partial agonism effect again is dependent on sublingual use. This is because buprenorphine’s metabolite Norbuprenorphine is capable of acting as a Mu opiod full agonist, and when used via injection, inhalation, or intranasal use; the rapid uptake of buprenorphine leads to a functional full agonist-like effect due to the rapid inhibition of the Mu-Opiod signaling which leads to corticomesolimbic dopamine release identical to full agonists which allows it to possess similar abuse potential to regular opiod/opiate medicines. Naltrexone is not to be confused with naloxone, a compound paired with buprenorphine to provide relief from (and regular maintenance for) opioid withdrawal and opioid dependence.
Alfentanil, sold under the brand name Alfenta among others, is a potent, short-acting synthetic opioid analgesic drug used for anesthesia in surgery. It is an analogue of fentanyl with around one-fourth to one-tenth the potency, one-third the duration of action, and an onset of action four times faster than that of fentanyl. Alfentanil has a pKa of approximately 6.5, which leads to a very high proportion of the drug being uncharged at physiologic pH, a characteristic responsible for its rapid-onset. It is an agonist of the μ-opioid receptor. While alfentanil tends to cause fewer cardiovascular complications than other similar drugs such as fentanyl and remifentanil, it tends to give stronger respiratory depression and so requires careful monitoring of breathing and vital signs. Almost exclusively used by anesthesia providers during portions of a case where quick, fast-acting (though not long-lasting) pain control is needed (as, for example, during nerve blocks), alfentanil is administered by the parenteral (injected) route for fast-onset and precise control of dosage. Discovered at Janssen Pharmaceutica in 1976, alfentanil is classified as a Schedule II drug in the United States.
Ortner's syndrome is a rare cardiovocal syndrome and involves recurrent laryngeal nerve palsy from cardiovascular disease. It was first described by Norbert Ortner (1865–1935), an Austrian physician, in 1897. Dysphagia caused by a similar mechanism is referred to as dysphagia aortica (also called dysphagia megalatriensis), or, in the case of subclavian artery aberrancy, as dysphagia lusoria. Due to compression of the recurrent laryngeal nerve, it can cause the hoarseness of the voice, which can also be a sign of mitral stenosis. A second Ortner's syndrome, Ortner's syndrome II, refers to abdominal angina.
Epulis fissuratum is a benign hyperplasia of fibrous connective tissue which develops as a reactive lesion to chronic mechanical irritation produced by the flange of a poorly fitting denture. More simply, epulis fissuratum is where excess folds of firm tissue form inside the mouth, as a result of rubbing on the edge of dentures that do not fit well. It is a harmless condition and does not represent oral cancer. Treatment is by simple surgical removal of the lesion, and also by adjustment of the denture or provision of a new denture. It is a closely related condition to inflammatory papillary hyperplasia, but the appearance and location differs.
Sources: en.wikipedia.org
A sealed container at room temperature, away from moisture and direct heat, is suitable for most solid material. Keeping the lid closed limits water uptake and caking. Long-term storage in a refrigerator is not necessary if the powder remains dry.
Heat, moisture, and prolonged time in solution promote conversion to creatinine. The reaction is faster at higher temperatures and at pH values far from neutral. Dry powder is much more stable than dissolved material.
Common methods include high-performance liquid chromatography for creatine and creatinine, plus water-content analysis by Karl Fischer titration. Heavy metals, residual solvents, and microbial limits may also be tested. A specification may list total creatine content and impurity limits.
Creatine is the base compound, while creatine monohydrate includes one water molecule per creatine molecule in its crystal structure. The monohydrate form is common in supplements and analytical standards. The body uses creatine itself after the water is removed or dissociated.